Frost & Sullivan Appoints Janesh Janardhanan as Global Partner
Sep 8, 2026 | By Devin Jacobs

Frost & Sullivan, a global analytics and growth advisory firm, has appointed Janesh Janardhanan as Global Partner and Head of its Subscriptions business.
SUMMARY
- Frost & Sullivan appointed Janesh Janardhanan as Global Partner.
- He will lead the subscriptions business.
- Frost & Sullivan provides business research and insights.
In his new role, Janardhanan will lead the financial performance of the company’s global subscription business, including its analytics services, subscriptions platform, and Growth Generator data platform.
The appointment highlights Frost & Sullivan’s focus on expanding its subscription-based services, which give clients access to business insights, growth opportunities, and decision-making tools.
Janardhanan will lead the strategy, business performance, and global expansion of these subscription platforms.
RECOMMENDED FOR YOU
[Funding alert] NYC-based Axion Ray Secures $17.5Million in Series A Round Funding
Devin Jacobs
Mar 13, 2024
Read More:MACOM’s net income triples to $100.7M as Margins Expand
Janardhanan brings experience in commercial leadership, analytics and growth strategy to his new role. He is a Harvard Business School graduate and holds an MBA and a Bachelor of Engineering from the National University of Singapore.
Under his leadership, Frost & Sullivan’s Subscriptions business will focus on expanding its coverage, improving its content and data, and strengthening the technology behind its platforms.
"I am honored to take on the leadership of Frost & Sullivan's Subscriptions business at such a pivotal moment," said Janesh Janardhanan, Global Partner and Head of Subscriptions, Frost & Sullivan. "Our analytics, data, and Growth Generator platforms sit at the heart of how clients identify and act on their next opportunities for growth.
About Frost & Sullivan
Founded in 1961, Frost & Sullivan helps companies improve growth, innovation and leadership. Its Growth Pipeline as a Service provides businesses with ongoing research, insight's and analytics to support growth strategies.
Read More:Aptar Pharma Announces Collaboration With Aceso Therapeutics








